240 related articles for article (PubMed ID: 20704554)
21. Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies.
Luk C; Compta Y; Magdalinou N; Martí MJ; Hondhamuni G; Zetterberg H; Blennow K; Constantinescu R; Pijnenburg Y; Mollenhauer B; Trenkwalder C; Van Swieten J; Chiu WZ; Borroni B; Cámara A; Cheshire P; Williams DR; Lees AJ; de Silva R
J Neurochem; 2012 Nov; 123(3):396-405. PubMed ID: 22862741
[TBL] [Abstract][Full Text] [Related]
22. Acetylated tau neuropathology in sporadic and hereditary tauopathies.
Irwin DJ; Cohen TJ; Grossman M; Arnold SE; McCarty-Wood E; Van Deerlin VM; Lee VM; Trojanowski JQ
Am J Pathol; 2013 Aug; 183(2):344-51. PubMed ID: 23885714
[TBL] [Abstract][Full Text] [Related]
23. Genetic bases of Progressive Supranuclear Palsy: the MAPT tau disease.
Borroni B; Agosti C; Magnani E; Di Luca M; Padovani A
Curr Med Chem; 2011; 18(17):2655-60. PubMed ID: 21568901
[TBL] [Abstract][Full Text] [Related]
24. Transgenic Drosophila models of Alzheimer's disease and tauopathies.
Iijima-Ando K; Iijima K
Brain Struct Funct; 2010 Mar; 214(2-3):245-62. PubMed ID: 19967412
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy.
Tacik P; Sanchez-Contreras M; DeTure M; Murray ME; Rademakers R; Ross OA; Wszolek ZK; Parisi JE; Knopman DS; Petersen RC; Dickson DW
Neuropathol Appl Neurobiol; 2017 Apr; 43(3):200-214. PubMed ID: 27859539
[TBL] [Abstract][Full Text] [Related]
26. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy.
Kraemer BC; Zhang B; Leverenz JB; Thomas JH; Trojanowski JQ; Schellenberg GD
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9980-5. PubMed ID: 12872001
[TBL] [Abstract][Full Text] [Related]
27. Frequency of tau mutations in familial and sporadic frontotemporal dementia and other tauopathies.
Stanford PM; Brooks WS; Teber ET; Hallupp M; McLean C; Halliday GM; Martins RN; Kwok JB; Schofield PR
J Neurol; 2004 Sep; 251(9):1098-104. PubMed ID: 15372253
[TBL] [Abstract][Full Text] [Related]
28. Role of the tau gene region chromosome inversion in progressive supranuclear palsy, corticobasal degeneration, and related disorders.
Webb A; Miller B; Bonasera S; Boxer A; Karydas A; Wilhelmsen KC
Arch Neurol; 2008 Nov; 65(11):1473-8. PubMed ID: 19001166
[TBL] [Abstract][Full Text] [Related]
29. Functional MAPT haplotypes: bridging the gap between genotype and neuropathology.
Caffrey TM; Wade-Martins R
Neurobiol Dis; 2007 Jul; 27(1):1-10. PubMed ID: 17555970
[TBL] [Abstract][Full Text] [Related]
30. Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies.
Strang KH; Croft CL; Sorrentino ZA; Chakrabarty P; Golde TE; Giasson BI
J Biol Chem; 2018 Feb; 293(7):2408-2421. PubMed ID: 29259137
[TBL] [Abstract][Full Text] [Related]
31. AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies.
Vingtdeux V; Davies P; Dickson DW; Marambaud P
Acta Neuropathol; 2011 Mar; 121(3):337-49. PubMed ID: 20957377
[TBL] [Abstract][Full Text] [Related]
32. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration.
Pittman AM; Myers AJ; Abou-Sleiman P; Fung HC; Kaleem M; Marlowe L; Duckworth J; Leung D; Williams D; Kilford L; Thomas N; Morris CM; Dickson D; Wood NW; Hardy J; Lees AJ; de Silva R
J Med Genet; 2005 Nov; 42(11):837-46. PubMed ID: 15792962
[TBL] [Abstract][Full Text] [Related]
33. Untangling the tauopathies: Current concepts of tau pathology and neurodegeneration.
Ling H
Parkinsonism Relat Disord; 2018 Jan; 46 Suppl 1():S34-S38. PubMed ID: 28789904
[TBL] [Abstract][Full Text] [Related]
34. MAPT mutations, tauopathy, and mechanisms of neurodegeneration.
Strang KH; Golde TE; Giasson BI
Lab Invest; 2019 Jul; 99(7):912-928. PubMed ID: 30742061
[TBL] [Abstract][Full Text] [Related]
35. Neuropathology of familial tauopathy.
Tsuboi Y
Neuropathology; 2006 Oct; 26(5):471-4. PubMed ID: 17080727
[TBL] [Abstract][Full Text] [Related]
36. Frontotemporal dementia and tauopathy.
Yoshiyama Y; Lee VM; Trojanowski JQ
Curr Neurol Neurosci Rep; 2001 Sep; 1(5):413-21. PubMed ID: 11898551
[TBL] [Abstract][Full Text] [Related]
37. The unfolded protein response is associated with early tau pathology in the hippocampus of tauopathies.
Nijholt DA; van Haastert ES; Rozemuller AJ; Scheper W; Hoozemans JJ
J Pathol; 2012 Apr; 226(5):693-702. PubMed ID: 22102449
[TBL] [Abstract][Full Text] [Related]
38. Invited review: Neuropathology of tauopathies: principles and practice.
Kovacs GG
Neuropathol Appl Neurobiol; 2015 Feb; 41(1):3-23. PubMed ID: 25495175
[TBL] [Abstract][Full Text] [Related]
39. Tau alteration and neuronal degeneration in tauopathies: mechanisms and models.
Brandt R; Hundelt M; Shahani N
Biochim Biophys Acta; 2005 Jan; 1739(2-3):331-54. PubMed ID: 15615650
[TBL] [Abstract][Full Text] [Related]
40. New insights into genetic and molecular mechanisms of brain degeneration in tauopathies.
Forman MS; Lee VM; Trojanowski JQ
J Chem Neuroanat; 2000 Dec; 20(3-4):225-44. PubMed ID: 11207421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]